Xla Wt + spry2 MO has 7 phenotype(s)

Images

Sources

Experiment + Assay

Phenotypes

Human Diseases

Fig. 4 A r1 c2, B

Sun J et al. (2020)

Xla Wt + spry2 MO

NF 19 (immunohistochemistry)

Anatomical Phenotype
abnormal cell migration abnormal retina abnormally decreased number of retinal progenitor cell

Fig. 5 r1c2, r2c2

Sun J et al. (2020)

Xla Wt + spry2 MO

NF 19 (immunohistochemistry)

Expression Phenotype
decreased amount pax6.L expression in eye primordium decreased amount rax.L expression in eye primordium

XB-PHENO-16578

Sun J et al. (2020)

Xla Wt + spry2 MO

NF 19 (immunohistochemistry)

Anatomical Phenotype
abnormal cell division increased size of the proliferative region

Fig. 1. E r1 c3

Sun J et al. (2020)

Xla Wt + spry2 MO

NF 33 (immunohistochemistry)

Anatomical Phenotype
abnormal cell migration abnormal retina abnormally decreased number of retinal progenitor cell

Fig. 2 A r1 c2

Sun J et al. (2020)

Xla Wt + spry2 MO

NF 33 (immunohistochemistry)

Anatomical Phenotype
abnormal cell migration abnormal retina

Fig 3 A r1 c2, C r1 c2

Sun J et al. (2020)

Xla Wt + spry2 MO

NF 33 (immunohistochemistry)

Anatomical Phenotype
abnormal cell migration abnormal retina

Fig. 1 D r1 c2

Sun J et al. (2020)

Xla Wt + spry2 MO

NF 36 (Microscopy)

Anatomical Phenotype
decreased size of the eye

microphthalmia